Deals this week: Jazz Pharmaceuticals, Kangmei Pharmaceutical


Ireland-based biopharmaceutical company Jazz Pharmaceuticals plans to raise $500m through a private placement of senior notes.

The company plans to use the proceeds towards general corporate purposes and business development.

Chinese pharmaceutical products provider Kangmei Pharmaceutical has completed a public offering of medium-term notes to raise CNY2bn ($299.58m).

Due 2022, the notes carry a coupon rate of 5.29%.